Despite the COVID-19 impact, the global Hepatitis B Diagnostic Tests Market grew at a solid year-on-year (YoY) rate, reaching a valuation of roughly US$ 872.5 Million in 2022. With the rising incidence of hepatitis B globally, the total market is expected to grow at a CAGR of 6.4% between 2022 and 2028, achieving a...